Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients

BACKGROUND: Frequently SARS-CoV-2 results in mild or moderate disease with potentially lower concentrations of antibodies compared to those that are hospitalised. Here, we validated an ELISA using SARS-CoV-2 trimeric spike glycoprotein, with targeted detection of IgG, IgA and IgM (IgGAM) using serum...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunol Methods
Main Authors: Cook, A.M., Faustini, S.E., Williams, L.J., Cunningham, A.F., Drayson, M.T., Shields, A.M., Kay, D., Taylor, L., Plant, T., Huissoon, A., Wallis, G., Beck, S., Jossi, S.E., Perez-Toledo, M., Newby, M.L., Allen, J.D., Crispin, M., Harding, S., Richter, A.G.
Format: Artigo
Jezik:Inglês
Izdano: Published by Elsevier B.V. 2021
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7997147/
https://ncbi.nlm.nih.gov/pubmed/33775672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2021.113046
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki